000 02370 a2200625 4500
005 20250513130944.0
264 0 _c19980112
008 199801s 0 0 eng d
022 _a0905-4383
024 7 _a10.1111/j.1600-0781.1997.tb00108.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGonzález, S
245 0 0 _aTopical or oral administration with an extract of Polypodium leucotomos prevents acute sunburn and psoralen-induced phototoxic reactions as well as depletion of Langerhans cells in human skin.
_h[electronic resource]
260 _bPhotodermatology, photoimmunology & photomedicine
_c
300 _a50-60 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial
650 0 4 _a5-Methoxypsoralen
650 0 4 _aAdjuvants, Immunologic
_xtherapeutic use
650 0 4 _aAdministration, Cutaneous
650 0 4 _aAdministration, Oral
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAntigens, CD1
_xanalysis
650 0 4 _aAntioxidants
_xtherapeutic use
650 0 4 _aDermatitis, Phototoxic
_xprevention & control
650 0 4 _aFemale
650 0 4 _aFurocoumarins
_xadverse effects
650 0 4 _aHumans
650 0 4 _aImmune Tolerance
_xdrug effects
650 0 4 _aLangerhans Cells
_xdrug effects
650 0 4 _aMale
650 0 4 _aMethoxsalen
_xadverse effects
650 0 4 _aMiddle Aged
650 0 4 _aNeoplasms, Radiation-Induced
_xetiology
650 0 4 _aPhotochemotherapy
650 0 4 _aPhotosensitizing Agents
_xadverse effects
650 0 4 _aPlant Extracts
_xtherapeutic use
650 0 4 _aPlants, Medicinal
650 0 4 _aRadiation Dosage
650 0 4 _aRadiation-Protective Agents
_xtherapeutic use
650 0 4 _aSkin
_xcytology
650 0 4 _aSkin Aging
_xdrug effects
650 0 4 _aSkin Neoplasms
_xetiology
650 0 4 _aSkin Pigmentation
_xdrug effects
650 0 4 _aSunburn
_xprevention & control
650 0 4 _aSunscreening Agents
_xtherapeutic use
650 0 4 _aUltraviolet Rays
_xadverse effects
650 0 4 _aVitiligo
_xdrug therapy
700 1 _aPathak, M A
700 1 _aCuevas, J
700 1 _aVillarrubia, V G
700 1 _aFitzpatrick, T B
773 0 _tPhotodermatology, photoimmunology & photomedicine
_gvol. 13
_gno. 1-2
_gp. 50-60
856 4 0 _uhttps://doi.org/10.1111/j.1600-0781.1997.tb00108.x
_zAvailable from publisher's website
999 _c9331103
_d9331103